Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas.
Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas. J Neurooncol. 2003 Feb; 61(3):187-96.
View in:
PubMed
subject areas
Adenoviridae
Antineoplastic Agents
Apoptosis
Camptothecin
Carboplatin
Carmustine
Drug Synergism
Glioma
Humans
I-kappa B Proteins
NF-kappa B
Repressor Proteins
Transcriptional Activation
Transfection
Tumor Cells, Cultured
Tumor Necrosis Factor-alpha
authors with profiles
James C. Cusack Jr., M.D.